Accessibility settings

This paper is in the following e-collection/theme issue:

Innovations in Clinical Trials and Research Data Management (148) Health Services in Resource-Poor Settings and LMICs (589) Vaccination and Immunization in the Digital Age (469)

Published on in Vol 23, No 8 (2021): August

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/28573, first published .
Box of vials with red caps, one vial labeled with medical information.

Use of Iris Scanning for Biometric Recognition of Healthy Adults Participating in an Ebola Vaccine Trial in the Democratic Republic of the Congo: Mixed Methods Study

Use of Iris Scanning for Biometric Recognition of Healthy Adults Participating in an Ebola Vaccine Trial in the Democratic Republic of the Congo: Mixed Methods Study

Authors of this article:

Trésor Zola Matuvanga1, 2, 3 Author Orcid Image ;   Ginger Johnson4 Author Orcid Image ;   Ynke Larivière2, 3 Author Orcid Image ;   Emmanuel Esanga Longomo5 Author Orcid Image ;   Junior Matangila1 Author Orcid Image ;   Vivi Maketa1 Author Orcid Image ;   Bruno Lapika6 Author Orcid Image ;   Patrick Mitashi1 Author Orcid Image ;   Paula Mc Kenna7 Author Orcid Image ;   Jessie De Bie2, 3 Author Orcid Image ;   Jean-Pierre Van Geertruyden2 Author Orcid Image ;   Pierre Van Damme3 Author Orcid Image ;   Hypolite Muhindo Mavoko1 Author Orcid Image
Article Authors Cited by (12) Tweetations (3) Metrics

Trésor Zola Matuvanga   1, 2, 3 , MD ;   Ginger Johnson   4 , PhD ;   Ynke Larivière   2, 3 , MPH ;   Emmanuel Esanga Longomo   5 , MD ;   Junior Matangila   1 , PhD ;   Vivi Maketa   1 , PhD ;   Bruno Lapika   6 , PhD ;   Patrick Mitashi   1 , PhD ;   Paula Mc Kenna   7 , MSc ;   Jessie De Bie   2, 3 , PhD ;   Jean-Pierre Van Geertruyden   2 , PhD ;   Pierre Van Damme   3 , PhD ;   Hypolite Muhindo Mavoko   1 , PhD

1 Department of Tropical Medicine, University of Kinshasa, Kinshasa, Congo, the Democratic Republic of the

2 Global Health Institute, University of Antwerp, Antwerp, Belgium

3 Centre for the Evaluation of Vaccination, University of Antwerp, Antwerp, Belgium

4 Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium

5 Division Provinciale de la Santé de la Province de la Tshuapa, Boende, Congo, the Democratic Republic of the

6 Department of Anthropology, University of Kinshasa, Kinshasa, Congo, the Democratic Republic of the

7 Janssen Pharmaceutica NV, Beerse, Belgium

Corresponding Author:

  • Trésor Zola Matuvanga, MD
  • Department of Tropical Medicine
  • University of Kinshasa
  • Avenue Université numéro 1, Commune de Lemba
  • Kinshasa
  • Congo, the Democratic Republic of the
  • Phone: 243 810046306
  • Email: zola.matuvanga@unikin.ac.cd